C ellular DNA is constantly subject to both endogenous and exogenous sources of damage. Abasic sites, also known as AP sites, are one of the most common forms of damage products. The spontaneous hydrolysis of nucleobases generates an estimated 10,000 AP sites per cell, per day 1 . AP site levels can be further elevated in the presence of exogenous damage agents, such as reactive oxygen species or alkylating agents [2] [3] [4] . AP sites are also generated enzymatically in vivo as an essential intermediate within the base excision repair (BER) pathway 5 . DNA base lesions, such as 8-oxoguanine and uracil, are normally efficiently excised by glycosylase enzymes to generate an AP site, which is further processed by the BER pathway 6, 7 . More recently, it was also suggested that BER and AP sites play a role in the maintenance of epigenetic DNA base modifications. Two pathways proposed to remove the DNA epigenetic marker 5-methylcytosine, active demethylation 8,9 and processive demethylation 10 , rely on separate glycosylase enzymes to convert key DNA bases at or around 5-methylcytosine into AP sites. Subsequent repair of the AP site by the BER pathway is suggested to restore unmodified cytosine into the genome. Together, these pathways highlight the further importance of BER beyond the repair of DNA damage.
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AP sites can be generated from DNA base modifications in vitro using enzyme chemistry. A variety of glycosylase enzymes have been identified that excise a single or set of structurally related modified nucleobases to form an AP site 11 . These glycosylases can therefore be used in vitro to convert DNA modifications into highly reactive AP sites that can potentially be subsequently detected. The exceptional specificity offered by glycosylases, even when a substrate is greatly outnumbered by the canonical DNA bases, is particularly useful when studying rare modifications, which may otherwise be difficult to target selectively. This approach is used to quantify uracil levels in genomic DNA 12 , and to enrich for DNA fragments that contain uracil and 8-oxoguanine to facilitate the mapping of these modifications by sequencing 13, 14 . When AP sites are not successfully repaired and instead persist in the genome, these lesions can lead to the stalling of polymerases and DNA strand breaks, as well as mutations due to the misincorporation of bases opposite the non-coding AP site 15, 16 . Mutations in APE1, the primary endonuclease responsible for initiating AP site repair in mammals, are associated with an increased risk of cancer and altered prognosis 17, 18 . Despite the severe consequences of persistent AP sites, there is still a lack of understanding as to their formation, persistence and location within genomic DNA. Fluorescent immunostaining of AP sites in DNA fibres suggested that AP sites formed in the presence of exogenous damage can be clustered and non-random 19, 20 ; however, little is known about where AP sites form in the genome and the sequence contexts in which they occur.
Methods to detect global levels of AP sites that utilize O-(biotinylcarbazoylmethyl) hydroxylamine, also known as aldehyde-reactive probe (ARP), have been described. In the ring-open form, the aldehyde group of AP sites can react with hydroxylamines such as ARP. The amount of ARP bound to DNA, and therefore number of reactive sites, can then be quantified by detection of the biotin moiety within ARP using dot-blot or enzyme-linked immunosorbent assays 21, 22 . A major drawback to using hydroxylamine condensation for the labelling of AP sites is that other reactive aldehydes identified in DNA can result in cross-reactivity 23 .
In particular, formylated bases, 5-formylcytosine (5-fC) and 5-formyluracil (5-fU), were shown to react with ARP 24, 25 . Quantitative mass spectrometry measurements revealed that the natural abundance of these bases can actually be higher than that of AP sites, with around 10 and 2.5 per 10 6 bases for 5-fC and 5-fU, respectively, measured in mouse embryonic stem cells, compared to 0.9 AP sites [26] [27] [28] . Thus, to correctly analyse the AP sites in genomic DNA there remains a chemoselectivity challenge to discern them in the presence of the naturally occurring bases 5-fC and 5-fU.
Here we describe a method for the selective detection of DNA AP sites in the presence of the formylated bases 5-fC and 5-fU, as well as the canonical G, C, A and T bases. We demonstrate that the approach can provide, with high chemical selectivity, a high-resolution map of AP sites within DNA that comprises AP sites or formylated bases. We extended this method to investigate the distribution of thymine modifications in Leishmania major genomic DNA at single-nucleotide resolution by mapping AP sites generated enzymatically by the glycosylase SMUG1 (single-strand-selective monofunctional uracil-DNA glycosylase 1). We also applied snAP-seq directly to Here we present snAP-seq, a chemical approach that selectively exploits the reactive aldehyde moiety at abasic sites to reveal their location within DNA at single-nucleotide resolution. Importantly, the approach resolves abasic sites from other aldehyde functionalities known to exist in genomic DNA. snAP-seq was validated on synthetic DNA and then applied to two separate genomes. We studied the distribution of thymine modifications in the Leishmania major genome by enzymatically converting these modifications into abasic sites followed by abasic site mapping. We also applied snAP-seq directly to HeLa DNA to provide a map of endogenous abasic sites in the human genome.
DNA from HeLa cells and revealed a relationship between AP sites and regions that contained genes when APE1 enzyme is depleted.
results
Chemical tagging of aldehyde residues in DNA. The 2′-deoxyribose ring at DNA AP sites is in equilibrium between the cyclic hemiacetal and acyclic form, where in the latter a reactive aldehyde group is exposed (Fig. 1a) . In addition to AP sites, the naturally occurring base modifications 5-fC and 5-fU also provide sources of reactive aldehydes in DNA and thus the selectivity of aldehyde tagging is crucial when any of these sites are studied. Hydrazine-and hydroxylamine-based probes have been used for the tagging of aldehyde residues in proteins and nucleic acids 25, [29] [30] [31] . However, the resulting hydrazones can be hydrolytically unstable, and oxime formation can require acidic conditions or nucleophilic catalysis, which promote additional AP site formation or DNA cleavage 1, 32 . More recently, the hydrazino-iso-Pictet-Spengler (HIPS) reaction was shown to form stable adducts at formylglycine residues within proteins at near-neutral pH 33 . We envisaged that the HIPS reaction would be compatible with AP sites under mild conditions. We designed HIPS probe 1, which bears an alkyne handle for ease of the subsequent functionalization via a copper(i)-catalysed azide-alkyne cycloaddition (CuAAC) (Fig. 1b) . AP-ODN (ODN, oligodeoxynucleotide), a synthetic DNA oligomer that contains a single AP site, reacts readily with probe 1 in two hours without side products (Supplementary Fig. 1 ). The reactivity of 5-fC has been shown to be reduced at near-neutral pH, and it is possible to achieve the chemoselective reaction of substituted hydrazines with 5-fU over 5-fC above pH 7 (ref. 24 ). Under our HIPS reaction conditions (pH 7.4), the reactivity with 5-fC-ODN was low (1%), whereas the reactivity of 5-fU-ODN was comparable to that of AP-ODN ( Supplementary  Fig. 1 ). Therefore, a way to discriminate further between these two aldehydes is necessary.
Selective isolation of DNA AP sites. During the sample preparation for next-generation sequencing (NGS), genomic DNA is broken into smaller fragments suitable for sequencing. To enrich for fragments that contain a DNA feature of interest relative to bulk genomic DNA, a tag such as biotin can be selectively introduced. Streptavidin beads are then used to capture tagged fragments. After NGS, a pile-up of sequencing reads is expected at loci where the target accumulates. This enrichment-based sequencing has been demonstrated for other DNA modifications 24, 25, 34 . We adopted this approach for snAP-seq by incorporating a biotin moiety onto 1-labelled DNA via a CuAAC reaction. The resulting adducts with an AP site, 5-fU or 5-fC were found to differ in their stabilities Tagging of the aldehyde residues followed by biotinylation through CuAAC and streptavidin pulldown enriches for all the reacted aldehydes, and the removal of the biotin tag by alkaline-cleavage occurs only at AP sites. The truncated DNA fragments with 5′-phosphate termini are then recovered and prepared for NGS. Sequencing reads stack up immediately after the position of captured AP sites due to the site-specific DNA cleavage step via base-catalysed elimination.
under alkaline conditions. Unfunctionalized AP sites underwent DNA strand scission via β or β-δ elimination at a high pH 35, 36 . The biotinylated 1-AP adduct was also quantitatively fragmented via the same chemistry on heating in basic conditions. In contrast, the analogous adducts on 5-fU or 5-fC did not show signs of degradation (Fig. 1c) . Most importantly, the elimination of the DNA backbone at the AP adduct generates two truncated DNA fragments. The fragment 3′ to the adduct no longer contains biotin and instead has a 5′-phosphorylated end. Elimination allows the biotin linker to be selectively cleaved off from the DNA strands that harbour AP sites, and thus separates these strands from streptavidin beads (Fig. 1d) , whereas DNA fragments that comprise 5-fU remain biotinylated. Therefore, a degree of cross-reactivity of HIPS probe 1 with 5-fU or 5-fC DNA modifications can be tolerated and filtered out by the methodology to isolate DNA fragments derived exclusively from AP sites.
To evaluate the selectivity of our approach in double-stranded DNA (dsDNA), synthetic dsDNA oligomers (100-105 bp) that contained a single AP site, 5-fU or 5-fC and an oligomer that contained only canonical bases to represent the bulk genomic DNA (GCAT DNA), were treated with 1 and then biotinylated. DNA was captured on streptavidin beads, followed by a mild alkaline treatment (100 mM NaOH, room temperature (r.t.)) to denature and release the unmodified complementary DNA strands. Under these conditions, biotinylated 1-AP adducts were confirmed to be stable towards elimination (Fig. 1c) . The elution of bound DNA was then achieved under alkaline-cleavage conditions (100 mM NaOH, 70 °C). Quantitative PCR (qPCR) of the recovered DNA confirmed that around a 100-fold selectivity was obtained for AP DNA relative to both 5-fC and unmodified GCAT DNA (Fig. 2a) . Although the 5-fU-1 adduct does not undergo DNA fragmentation under alkaline-cleavage conditions (Fig. 1c) , near-quantitative recovery of 5-fU DNA occurred after this step, probably due to the disruption of the biotin-streptavidin interaction under harsh conditions. As released 5-fU DNA remains biotinylated, these strands were removed by further incubation with streptavidin beads. AP DNA remains in the supernatant during this step, whereas 5-fU DNA was successfully recaptured and less than 5% was recovered (Fig. 2b) . Therefore, the high selectivity for AP-derived DNA is achievable after two successive rounds of enrichment.
Mapping AP sites in dsDNA. With a chemical method for the selective enrichment of AP sites in hand, we turned our attention to combining this with NGS to create a strategy to map AP sites in genomic DNA (Fig. 2c) . First, a custom P7 adapter was introduced to the DNA sequences by ligation. DNA was enriched on the streptavidin beads and then released by alkaline-cleavage. The undesired recovery of 5-fU DNA was removed using streptavidin, followed by primer extension on the recovered fragments. Ligation of the P5 adapter and PCR amplification then generated the sequencing library. The stepwise introduction of sequencing adapters ensures that only the 5′-phosphates selectively exposed at AP sites by elimination are available for ligation. Sequencing libraries are therefore selective for DNA derived from captured AP sites, and the non-specific recovery of untagged DNA is reduced.
To validate that this enrichment strategy is compatible with NGS, sequencing libraries were prepared using equal input amounts of AP, 5-fU, 5-fC and GCAT DNA. Of the total reads obtained after snAP-seq, 98% aligned to AP DNA (Fig. 2d) . Furthermore, 95% of reads begin exactly one nucleotide after the AP position, which results in a stacking of reads immediately after the AP site. Thus, snAP-seq allows the single-base resolution detection of AP sites with chemical selectivity. In a control experiment, in which the same input DNA was sequenced without streptavidin enrichment, the AP-strand was heavily underrepresented (1.6% of the total reads) ( Fig. 2d and Supplementary Fig. 10 ). Here, AP DNA is -fU DNA, after first streptavidin enrichment. DNA was recovered under alkaline-cleavage conditions (100 mM NaOH, 70 °C) before neutralization and purification. DNA was quantified by qPCR and normalized to input DNA. The recovery of each DNA sequence was compared to that of the AP DNA and represented as a fold enrichment of AP DNA. Apart from GCAT DNA, all the primers were designed 3′ to each modification and therefore the cleavage site expected to allow DNA amplification (mean ± s.e.m. of three replicates). b, Recovery of DNA sequences after the second streptavidin enrichment. AP DNA remains unbound and is recovered from the supernatant and 5-fU DNA is captured on the beads. DNA was quantified by qPCR and normalized to the amount of DNA recovered after the first streptavidin enrichment. The results from three replicates are plotted. c, Library-preparation workflow of snAP-seq. Red asterisks represent biotinylated probe 1. The first column represents DNA containing AP sites, the second represents DNA containing 5-fU and the third represents DNA that is not reactive towards probe 1. d, Distribution of reads that align to each model DNA sequence after NGS. The number of reads of each ODN was normalized to the corresponding reverse strand in the input sample (Supplementary Table 3 ). Only the modification-containing forward strands of each ODN were analysed.
not efficiently amplified by PCR due to the stalling of high-fidelity polymerases at the AP sites 16 . In contrast, the snAP-seq protocol (Fig. 2c) cleaves the DNA at the AP site and sequences the bases immediately adjacent, which prevents polymerase stalling during PCR amplification.
Mapping thymine modifications in the L. major genome. In the L. major genome, the DNA base modification 5-hydroxymethyluracil (5-hmU) replaces approximately 0.01% of all thymine (T) residues 37, 38 . 5-hmU is associated with the hypermodified base 5-(β-glucopyranosyl) hydroxymethyluracil (base J) 37, 39, 40 , which also occurs in this genome. Studies on the quantification and mapping of both of these modifications revealed potentially interesting roles in L. major and other trypanosomatid genomes 38, 39 . The mapping methods used in these studies allows the identification of broad regions in which modifications are enriched; however, the precise loci and sequence context of the modifications remain unclear. The glycosylase SMUG1 can be used biochemically to excise 5-hmU from genomic DNA to generate an AP site, as well as other thymine modifications, which include 5-fU, uracil and 5-hydroxyuracil 41 . In contrast, base J is not a substrate ( Supplementary Fig. 7 ). Therefore, we envisaged exploiting snAPseq in combination with SMUG1 to map 5-hmU at a single-base resolution in the L. major genome. Genomic L. major DNA was sonicated, treated with SMUG1 to replace the T modifications with AP sites and then snAP-seq was applied.
After alignment of the sequencing reads obtained by SMUG1-snAP-seq, pile-ups of sequenced reads appear. Reads within these enriched regions are aligned with a common sequencing start site, which corresponds to the base immediately 3′ to the SMUG1-generated AP sites (Fig. 3) . These sharp increases in coverage were used to detect individual SMUG1-sensitive-modified thymine sites when compared to input DNA. A total of 3,200 high-confidence sites were called by SMUG1-snAP-seq across two technical replicates (false discovery rate < 10
−10
). Defining the start position of sequencing read 1 as position '1' in the forward strand, and '-1' in the reverse strand, we analysed the base composition of position '0' , which represents the captured SMUG1-generated AP site. Over 98% of the called sites correspond to a thymine in the reference genome, which is the canonical precursor for 5-hmU (Fig. 4a) and suggests that this method is highly accurate and artefacts that arise from the non-specific pile-up of reads is low. In the absence of SMUG1 treatment, no significant sites were called, which suggests any endogenous AP sites in these samples do not accumulate at specific loci. Comparison of the relative read counts around the 3,200 SMUG1-sensitive sites shows that the SMUG1 untreated libraries closely resemble the input DNA (Fig. 4b) , which further confirms that the signal observed by SMUG1-snAP-seq is specific to enzymatic AP site generation.
We compared our data set to a previously reported low-resolution map of 5-hmU in L. major 38 . Of the 139 reported 5-hmUenriched regions, there was a 76% overlap with the high-confidence SMUG1-snAP-seq sites (Fig. 5a) . Our results also show that, at the single nucleotide level, SMUG1-sensitive sites are highly clustered within these broad stretches (Fig. 4c) . Low-resolution mapping 38 previously identified an enrichment of G-rich motifs, TpT dinucleotides and longer T stretches within the broad 5-hmU peaks; however, the exact sequence context and strand specificity is lost. Motif analysis using the sites identified here by SMUG1-snAP-seq shows a strong enrichment within TpG dinucleotides (Fig. 5b) , as well as a preference for G and T bases on the 5′ side of 5-hmU (GpT and TpT) (Fig. 5c) .
As the SMUG1-snAP-seq protocol fragments DNA at the captured AP sites, multiple SMUG1-generated AP sites that occur in the same individual DNA strand are likely to be represented as only one site, which corresponds to the one closest to the 3′ end.
The identification of closely clustered SMUG1-snAP sites (Fig. 3) suggests that partially incomplete reactivity may be aiding the identification of the dense SMUG1-snAP sites.
As SMUG1 recognizes a number of substrates, we also carried out UNG-snAP-seq (UNG, uracil-N-glycosylase) by treating L. major DNA with UNG and then applying snAP-seq. Unlike SMUG1, UNG displays a very high specificity for uracil and is not able to excise 5-substituted uracil derivatives such as 5-hmU 42 . No sites were detected after UNG-snAP-seq (false discovery rate < 10 −10 ), which suggests that the sites identified by SMUG1-snAP-seq are specific to oxidized thymine derivatives (Supplementary Fig. 15 ).
Mapping endogenous AP sites in the human genome. Next, we used snAP-seq to investigate directly the distribution of endogenous AP sites in the human genome. As HeLa cells are well-characterized and easy to manipulate, we chose this cell line for our study. AP sites are chemically labile at high pH 35, 36 , whereas at low pH the generation of additional AP sites as artefacts via depurination is accelerated 1, 43 . Therefore, to maintain an accurate and sensitive detection it is important to ensure that all the DNA processing steps that precede chemical tagging do not alter the AP site landscape. DNA extraction and sonication are two key steps used here between cell harvesting and the HIPS reaction, and the effect of both steps on the pulldown efficiency was assessed. Synthetic AP and GCAT DNA were subjected to each of these steps and the extent of enrichment was measured by qPCR. No significant change in the enrichment was observed compared to untreated DNA (P > 0.9999), which suggests that these steps do not introduce detectable artefacts (Fig. 6a) .
In mammalian cells, APE1 is the main endonuclease to initiate repair at AP sites and accounts for over 95% of the AP endonuclease activity 44 . To understand further the distribution of AP damage, we used the short interfering RNA (siRNA)-mediated knockdown of APE1 to study the AP landscape in genomic DNA before completion of the repair by BER. Western blot analysis confirmed that around a 90% knockdown of APE1 protein was achieved compared to cells treated with non-targeting control siRNA (Fig. 6b) .
After snAP-seq, we were not able to detect nucleotides with AP accumulation (Supplementary Fig. 15 ). The results immediately tell us that AP sites do not accumulate at single-nucleotide sites in the genome across the population of HeLa cells, in contrast with 5-hmU sites in L. major, which are likely to be installed enzymatically at specific thymine sites. Given the additional potential for oxidative damage in mitochondrial DNA, we looked to see whether damage accumulates preferentially here. No individual sites were detected, despite the greater sequencing depth at 200× for mitochondria, compared to 10× for the nuclear genome ( Supplementary Fig. 15 ).
We therefore assessed whether AP sites accumulate within stretches of the genome by identifying peaks, rather than single sites, that are enriched compared to the input DNA by integrating signals in both libraries in windows 45 . For cells treated with control-siRNA, a total of 14,110 peaks were detected when only high-confidence peaks that appear in at least three out of four replicates were considered. This increases to 25,080 peaks with APE1 knockdown, 10,387 (74% of the siRNA-control peaks) of which are in common (Fig. 6c) . This suggests that even when BER is active, some AP sites persist long enough in the genome to be captured chemically, whereas the lifetime of others is affected by the presence of APE1.
Next, high-confidence AP peaks were analysed in the context of gene features (Fig. 6f) . For the siRNA control, AP peaks were weakly enriched only within intergenic regions of the genome (false discovery rate < 0.05). The pattern changed with APE1 knockdown, in which an enrichment of AP peaks was observed at regulatory and transcribed regions, which included promoters, 5′-and 3′-UTRs and exons (false discovery rate < 0.05). Peaks in common between the two siRNA treatments were weakly enriched in promoters, exons and intergenic regions, but the majority of peaks (62%) were within intergenic regions.
The distribution of AP peaks was also studied in relation to both chromatin accessibility and histone modifications. An overall enrichment of peaks, after both control and APE1 siRNA treatment, was observed for genomic locations associated with open chromatin, which suggests that these regions are more prone to damage ( Supplementary Fig. 17 , false discovery rate < 0.05). An enrichment of peaks was observed at areas of the genome associated with repressive histone marks (H3K27me3 and H3K9me3). A weaker enrichment was also seen at activating histone marks (H3K27ac and H3K4me3) for APE1-deficient cells, which was not observed for cells treated with the control siRNA ( Supplementary Fig. 17) .
We analysed the average base composition of the nucleotide immediately 5′ to the start of sequencing reads (position 0) globally across all the reads within the sequencing libraries in an unbiased manner (Fig. 6g) . For both control-and APE1-siRNA-treated cells, an enrichment in the purines, guanine and adenine was seen for the base at position 0 relative to input libraries (P < 0.05).
Discussion
Using synthetic DNA, we demonstrated that the chemistry of snAP-seq can detect the position of AP sites with a high specificity. Enrichment was observed for AP sites relative to the unmodified DNA, as well as the naturally occurring aldehyde-containing bases 5-fC and 5-fU. Although some methods of detecting AP sites may be confounded by the presence of these bases 2, 20, 22, 46 , snAP-seq targets AP sites with a high selectivity. In addition to enrichment over the input DNA, a site-specific DNA cleavage step generated an increase in sequencing coverage exactly one nucleotide after the captured AP sites, and thus the approach can reveal AP sites at single-nucleotide resolution.
We demonstrated that snAP-seq is easily extendable to map base modifications for which a DNA glycosylase is available. This was exemplified in the SMUG1-snAP-seq analysis of L. major DNA, which revealed that regions previously shown to be enriched in T modifications, such as 5-hmU, were densely modified. The high-resolution data generated here also show that within these broad regions the distribution of T modifications is not random, high-resolution mapping techniques has potential in further elucidating the role and function of such base modifications. In addition to T-modification mapping via AP site generation by SMUG1, snAP-seq can be coupled with other glycosylases. UNG 6 , hOGG1 7 or TDG 9 may also find interesting applications in different biological contexts when combined with this method.
We applied snAP-seq to elucidate endogenous AP sites in the human genome, using DNA from HeLa cells. In addition to studying BER competent cells, we depleted cellular levels of APE1 to investigate the preferences of AP site formation in genomic regions before repair. We found that AP sites do not accumulate site specifically at the single-nucleotide level, even when APE1 is depleted. This suggests a level of stochasticity for the exact site of damage across a population of cells, such that stretches of the genome more prone to damage can be identified. Alternatively, the knockdown of APE1 alone may not be sufficient to observe a substantial accumulation of AP sites at a given location. APE2 is also present in mammals and may become more active in the absence of APE1 activity. Similar to our findings, methods capable of detecting DNA doublestrand breaks at nucleotide resolution have found that this type of damage also accumulates within broadened peaks 47 . Using peak-based analysis, a high degree of overlap was seen between peaks in control-and APE1-siRNA-treated cells. AP peaks detected in control cells accumulate even in the presence of APE1, suggestive of a basal level of damage that exists largely in intergenic regions of the genome. On the knockdown of APE1, an additional 14,693 peaks were detected. AP damage here was found to be enriched within genic and regulatory regions, which suggests that APE1 may be responsible for repairing damage in these regions. This general trend is in line with that observed for the oxidative DNA damage marker, 8-oxoguanine, where levels increase in promoters and 5′-and 3′-UTRs on knockout of the repair enzyme OGG1 in mouse embryonic fibroblasts 48 . Our results also suggest that in both APE1-depleted and control cells, there is a global preference for AP sites derived from depurination compared to depyrimidination (Fig. 6g) . This is consistent with in vitro studies that show that purines are less stable than pyrimidines towards hydrolysis 49 . In summary, we present a versatile method in which both endogenous AP sites and those selectively generated in vitro can be mapped at high resolution. We investigated both of these classes of AP sites in two different genomes. Our method was combined with SMUG1 glycosylase treatment to provide a single-nucleotide resolution map of 5-hmU in the L. major genome. Future applications of snAP-seq and glycosylase-coupled variations of this method will be valuable for studies on both DNA damage and base modifications.
Methods
For the reaction with 1 and biotinylation, purified genomic DNA was treated with 1 (10 mM) in sodium phosphate buffer (40 mM, pH 7.4) at r.t. for 2 h, then purified using a mini Quick Spin Oligo Column (Roche) according to the manufacturer's instructions. The eluted DNA was incubated with CuBr (250 μM), tris-hydroxypro pyltriazolylmethylamine (THPTA) (1.25 mM) and biotin-PEG3-azide (500 μM) at 37 °C for 2 h. Samples were purified using a prewashed Amicon Ultra-0.5 ml 10K centrifugal filter (500 μl of water) and washed on the filter with water (450 μl) and Tris-HCl buffer (450 μl, 10 mM, pH 7.4) and eluted in Tris-HCl buffer (50 μl). For the P7 adapter ligation, sequencing adapters were ligated onto labelled DNA using a NEBNext Ultra II DNA library preparation kit according to the manufacturer's instructions, with the exception that the adapter was replaced with a custom P7 adapter (2.5 μl). Ligated DNA was then treated with shrimp alkaline phosphatase (3 U, NEB) in CutSmart Buffer (NEB) for 30 min at 37 °C, before purification with AMPure XP beads (1.4 × volume) and eluted in Tris-HCl (48 μl, 10 mM, pH 7.4).
For the streptavidin pulldown, magnesphere streptavidin beads (50 μl, Promega) were pre-washed three times with 1× binding buffer (5 mM Tris pH 7.5, 0.5 mM EDTA, 1 M NaCl, 0.05% Tween 20) and resuspended in 50 μl of 2× binding buffer (10 mM Tris pH 7.5, 1 mM EDTA, 2 M NaCl, 0.1% Tween 20) . Poly(deoxyinosinic-deoxycytidylic) acid (2 μg, Thermo Scientific) was added to ligated DNA samples and incubated with resuspended streptavidin beads at r.t. for 15 min. Beads were washed with 1× binding buffer (6 × 500 μl), then incubated with NaOH (100 μl, 100 mM) at r.t. for 10 min. The beads were washed again with NaOH (100 μl, 100 mM) followed by 1× binding buffer (3 × 500 μl). DNA was eluted in NaOH (50 μl, 100 mM) at 70 °C for 15 min and quenched immediately with Tris-HCl (25 μl, 500 mM, pH 7.0). A fresh sample of prewashed streptavidin beads (75 μl) was incubated with poly(deoxyinosinic-deoxycytidylic) acid (2 μg) and resuspended in 2× binding buffer (75 μl), to which the neutralized DNA eluent was added. The sample was incubated at r.t. for 15 min, then the supernatant was separated and purified using a single-stranded DNA clean and concentrator (Zymo Research) according to the manufacturer's guidelines with the exception that the IIC column step was omitted.
For the primer extension, reaction volumes (30 μl) that contained purified single-stranded DNA, deoxyribonucleotide triphosphates (200 μM), P7 primer (1 μM) and NEBuffer 2 were heated to 95 °C for 1 min, annealed at 65 °C for 30 s and held at 37 °C for 30 min, at which point the Klenow fragment of DNA polymerase I (3′ → 5′ -exo-, NEB, 2 U) was added. The synthesized dsDNA was purified using a DNA clean and concentrator 5 kit (Zymo Research) according to the manufacturer's instructions and eluted in Tris-HCl (10 mM, pH 7.4).
For the P5 adapter ligation, DNA (22.5 μl), Blunt/TA ligase master mix (25 μl, NEB) and custom P5 adapter (2.5 μl) were incubated at 20 °C for 30 min. Libraries were purified with AMPure XP beads (1.5× volume) and eluted in Tris-HCl (10 mM, pH 7.4) before amplification using a Q5 hot start high-fidelity master mix (NEB) with library amplification primers (10 μM each). Libraries were quantified using a KAPA library quantification kit and sequenced on either an Illumina MiSeq or NextSeq machine.
For the input library preparation, DNA was treated in the same way as above with the NEBNext kit, with the exception that the custom P7 adapter was substituted by TruSeq indexed adapters (Illumina, 2.5 μl). Samples were purified twice using AMPure XP beads (1.0× volume) to remove excess adapters and then amplified as in snAP-seq.
For the analysis of sequencing data, raw sequencing reads were processed and alignments generated and analysed using Unix tools, R and Python scripts (details given in the Supplementary Information). We have released all the computational code in the accompanying manuscript's GitHub page (https://github.com/sblabbioinformatics/snAP-seq). The raw sequencing data and all the relevant snAP-seq sites and peaks are deposited in the ArrayExpress database at EMBL-EBI under accession number E-MTAB-7152.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
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Policy information about availability of computer code Data collection LC-MS was performed on an Amazon ESI-MS (Bruker) connected to a Dionex UltiMate 3000 UHPLC system (Thermo Fisher Scientific), and data was analysed using Bruker Compass DataAnalysis 4.2. DNA sequencing data was collected using an Illumina Nextseq 500 system. Data analysis qPCR data was analysed using CFX Software manager 3.1. Western blot data was analysed using ProteinSimple Compass for SW. FastQC v0.11.3 was used to evaluate the quality of sequencing libraries. Sequencing reads were trimmed using cutadapt v1.12, aligned using samtools v1.3.1 and duplicates were marked by sambamba v0.6.5. bwa v0.7.15-r1140 was used to align reads. Single-nucleotide AP sites were called by using bedtools v2.27.0 to obtain sequencing coverage across libraries, followed by comparative assessment of counts from snAP-seq enriched and input libraries using edgeR v3.16.5. Peak calling was performed using macs2 v2.1.1.20160309. Motif analysis was carried out using the dreme tool in meme v4.11.2. Analysis of genomic associations of peaks was performed using the Genomic Association Tester (GAT). Volcano plots were generated ggplot2 v2.2.1, sequence logo plots were generated using the ggseqlogo library in R, and all other graphs were plotted using either Prism 7 (Graphpad), or visualized with R.
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